Literature DB >> 14456834

[Behavior of the serum level after intravenous injections of ajmaline].

H KLEINSORGE, P GAIDA.   

Abstract

Entities:  

Keywords:  ARRHYTHMIA/therapy; RAUWOLFIA/blood

Mesh:

Substances:

Year:  1962        PMID: 14456834     DOI: 10.1007/bf01482017

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


× No keyword cloud information.
  3 in total

1.  [A colorimetric determination method for small amounts of ajmalin in pharmaceutical preparations].

Authors:  H KLEINSORGE; P GAIDA
Journal:  Pharmazie       Date:  1961-03       Impact factor: 1.267

2.  [Therapy of arrhythmias with the Rauwolfia alkaloid ajmalin].

Authors:  H KLEINSORGE; E VOELKNER
Journal:  Munch Med Wochenschr       Date:  1960-11-18

3.  [Therapy of disorders of the heart rhythm].

Authors:  K SPANG
Journal:  Dtsch Med Wochenschr       Date:  1957-04-26       Impact factor: 0.628

  3 in total
  5 in total

1.  The pharmacokinetics and organ distribution of ajmaline and quindine in the mouse.

Authors:  H Iven
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-05       Impact factor: 3.000

2.  Haemodynamic effects of ajmaline in man.

Authors:  H Saetre; G Ahlmark; G Ahlberg
Journal:  Eur J Clin Pharmacol       Date:  1974-07-26       Impact factor: 2.953

3.  Effects of ajmaline on contraction patterns of isolated rat gastric antrum and portal vein smooth muscle strips and on neurogenic relaxations of gastric fundus.

Authors:  Robert Patejdl; Alina Gromann; Dietmar Bänsch; Thomas Noack
Journal:  Pflugers Arch       Date:  2019-05-02       Impact factor: 3.657

4.  Ajmaline test in a patient with chronic renal failure. A pharmacokinetic and pharmacodynamic study.

Authors:  R Padrini; L Compostella; D Piovan; A Javarnaro; F Cucchini; M Ferrari
Journal:  Clin Pharmacokinet       Date:  1991-08       Impact factor: 6.447

5.  Pharmacokinetics and electrophysiological effects of intravenous ajmaline.

Authors:  R Padrini; D Piovan; A Javarnaro; F Cucchini; M Ferrari
Journal:  Clin Pharmacokinet       Date:  1993-11       Impact factor: 6.447

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.